Objective:
The article examines the objective, findings, and clinical context described in Preparing for the AI-Enabled Practice.
Approach:
- Distinguish AI from hype: Daigrepont urges practice leaders to clarify what AI is and is not, and to consider whether AI will be sold as a standalone product or become a feature within existing tools.
- Review commitments: Before contracting for AI solutions, assess intellectual-property ownership, data use, remedies if a product fails to perform as promised, and termination rights.
- Adopt cautiously: He encourages curiosity and exploration while advising practices to approach adoption with skepticism and understand their contractual obligations.
Key Findings:
- Daigrepont compares the current AI market to the earlier EHR market, which he says once had more than 600 vendors and later contracted to a handful.
- He notes that AI features may already be embedded in commonly used products, including search and office software.
- He warns that technology vendors may disappear within a few years, potentially leaving practices with commitments to products that are no longer available.
Interpretation:
The presentation frames AI adoption as a strategic and contractual decision, not simply a technology purchase.
Limitations:
- The context is a speaker’s preview of an AAO 2026 Meeting course, not a research study or systematic review.
- No comparative data on AI products, outcomes, or contract terms are provided.
Conclusion:
Daigrepont says the Coker Group offers no-cost reviews of vendor contracts for the Academy.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.